<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02583958</url>
  </required_header>
  <id_info>
    <org_study_id>FI-14-06-310 3166</org_study_id>
    <nct_id>NCT02583958</nct_id>
  </id_info>
  <brief_title>Assessment of Efficacy &amp; Safety for a New Wound Dressing Urgo 310 3166 in the Local Treatment of VLU or Mixed Leg Ulcers</brief_title>
  <official_title>Assessment of Efficacy and Safety for a New Wound Dressing URGO 310 3166 in the Local Treatment of Venous or Mixed Leg Ulcers: A European, Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires URGO</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires URGO</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local
      treatment of venous or mixed leg ulcers: a European, randomised clinical trial.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relative regression of wound surface area</measure>
    <time_frame>week 20</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of debrided wounds</measure>
    <time_frame>at each clinical evaluation up to 20 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse events as assessed by the investigator according to a classification MedDRA</measure>
    <time_frame>between inclusion and week 20</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's Quality of Life</measure>
    <time_frame>at inclusion visit and at week 20 or at the end of study treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Leg Ulcers</condition>
  <arm_group>
    <arm_group_label>Device Urgo 3103166</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Soft-adherent hydro-desloughing dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Device Aquacel Extra</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hydrofibre dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Urgo 3103166</intervention_name>
    <description>URGO 310 3166 dressing should be changed as often as required (let to the Investigator's convenience). The dressing change frequency is based on the exudate level and the clinical progress of the wound (up to 7 days).</description>
    <arm_group_label>Device Urgo 3103166</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aquacel Extra</intervention_name>
    <description>Aquacel Extra hydrofibre dressing can be left in place up to 7 days, where clinically indicated.</description>
    <arm_group_label>Device Aquacel Extra</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 18 years old who has provided his/her written informed consent,

          -  Patient who can be monitored by the same investigation team throughout the whole
             duration of the study,

          -  Patient who agrees to wear an effective venous compression system every day,
             associated with the trial dressing,

          -  Leg ulcer with an Ankle Brachial Pressure Index (ABPI) not less than 0.7 and not more
             than 1.3,

          -  Ulcer area &gt; or equal to 5cm2,

          -  Ulcer duration &gt; or equal to 6 months,

          -  Ulcer presenting a the surface wound bed covered with 50% or more by sloughy tissue,

          -  Moderately or heavily exudative ulcers.

        Exclusion Criteria:

          -  Clinical infection on the wound bed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sylvie Meaume, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Rothschild - Paris - France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sylvie Meaume, MD</last_name>
    <email>sylvie.meaume@rth.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Meaume, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 12, 2015</study_first_submitted>
  <study_first_submitted_qc>October 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2015</study_first_posted>
  <last_update_submitted>October 20, 2015</last_update_submitted>
  <last_update_submitted_qc>October 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carboxymethylcellulose Sodium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

